Spontaneous cell proliferation is associated with poor sensitivity to glucocorticoids in patients infected with HTLV

Cell Proliferation

Volumn 40, Issue 1, 2007, Pages 64-74

  Lopes, R P ^a   Menna Barreto, M ^a   Bauer, M E ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LEUKEMIA; LYMPHOCYTE; MALE;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELLS, CULTURED; DEXAMETHASONE; DRUG RESISTANCE; FEMALE; GLUCOCORTICOIDS; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 33846211459     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2007.00419.x     Document Type: Article

References (40)

1. Alcantara LC, Shindo N, Van Dooren S, Salemi M, Costa MC, Kashima S, Covas DT, Vandamme AM, Galvao-Castro B (2003) Brazilian HTLV type 2a strains from intravenous drug users (IDUs) appear to have originated from two sources: Brazilian Amerindians and European/North American IDUs. AIDS Res. Hum. Retroviruses 19, 519-523.
2. Araujo AQ, Afonso CR, Leite AC, Dultra SV (1993) Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP). Arq. Neuropsiquiatr. 51, 325-328.
3. Bhigjee AI, Wiley CA, Wachsman W, Amenomori T, Pirie D, Bill PL, Windsor I (1991) HTLV-I-associated myelopathy: clinicopathologic correlation with localization of provirus to spinal cord. Neurology 41, 1990-1992.
4. Blattner WA, Blayney DW, Robert-Guroff M, Sarngadharan MG, Kalyanaraman VS, Sarin PS, Jaffe ES, Gallo RC (1983) Epidemiology of human T-cell leukemia/lymphoma virus. J. Infect. Dis. 147, 406-416.
5. Cartier LM, Cea JG, Vergara C, Araya F, Born P (1997) Clinical and neuropathological study of six patients with spastic paraparesis associated with HTLV-I: an axomyelinic degeneration of the central nervous system. J. Neuropathol. Exp. Neurol. 56, 403-413.
6. Collaziol D, Preissler T, Bauer M (2002) Avaliação da proliferação linfocitária e sensibilidade a glicocorticóides por ensaios colorimétricos. Rev. Med. PUC/RS 12, 226-231.
7. Franchini G (1995) Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood 86, 3619-3639.
8. Gessain A, Gout O (1992) Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann. Intern. Med. 117, 933-946.
9. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2, 407-410.
10. Goubau P, Liu HF, De Lange GG, Vandamme AM, Desmyter J (1993) HTLV-II seroprevalence in pygmies across Africa since 1970. AIDS Res. Hum. Retroviruses 9, 709-713.
11. Heneine W, Kaplan JE, Gracia F, Lal R, Roberts B, Levine PH, Reeves WC (1991) HTLV-II endemicity among Guaymi Indians in Panama. N. Engl. J. Med. 324, 565.
12. Hjelle B, Appenzeller O, Mills R, Alexander S, Torrez-Martinez N, Jahnke R, Ross G (1992) Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 339, 645-646.
13. Hjelle B, Zhu SW, Takahashi H, Ijichi S, Hall WW (1993) Endemic human T cell leukemia virus type II infection in southwestern US Indians involves two prototype variants of virus. J. Infect. Dis. 168, 737-740.
14. Hollsberg P (1997) Pathogenesis of chronic progressive myelopathy associated with human T-cell lymphotropic virus type I. Acta Neurol. Scand. Suppl. 169, 86-93.
15. Ijichi S, Eiraku N, Osame M, Izumo S, Kubota R, Maruyama I, Matsumoto M, Niimura T, Sonoda S (1989) Activated T lymphocytes in cerebrospinal fluid of patients with HTLV-I-associated myelopathy (HAM/TSP). J. Neuroimmunol. 25, 251-254.
16. Itoyama Y, Minato S, Kira J, Goto I, Sato H, Okochi K, Yamamoto N (1988) Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology 38, 1302-1307.
17. Iwasaki Y (1990) Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J. Neurol. Sci. 96, 103-123.
18. Juruena MF, Cleare AJ, Bauer ME, Pariante CM (2003) Molecular mechanisms of glucocorticoid receptor sensitivity and relevance to affective disorders. Acta Neuropsychiatr. 15, 354-367.
19. Khabbaz RF, Hartel D, Lairmore M, Horsburgh CR, Schoenbaum EE, Roberts B, Hartley TM, Friedland G (1991) Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection? J. Infect. Dis. 163, 252-256.
20. Maloney EM, Biggar RJ, Neel JV, Taylor ME, Hahn BH, Shaw GM, Blattner WA (1992) Endemic human T cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J. Infect. Dis. 166, 100-107.
21. Mann DL, Martin P, Hamlin-Green G, Nalewaik R, Blattner W (1994) Virus production and spontaneous cell proliferation in HTLV-I-infected lymphocytes. Clin. Immunol. Immunopathol. 72, 312-320.
22. Matsushita K, Arima N, Ohtsubo H, Fujiwara H, Arimura K, Kukita T, Ozaki A, Hidaka S, Matsumoto T, Tei C (2002) Poor response to prednisolone of idiopathic thrombocytopenia with human T-lymphotropic virus type I infection. Am. J. Hematol. 71, 20-23.
23. Menna-Barreto M (2003) A 96-month longitudinal study of HTLV-II-associated myelopathy. AIDS Res. Hum. Retroviruses 19, S14.
24. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65, 55-63.
25. Murphy EL, Blattner WA (1988) HTLV-I-associated leukemia: a model for chronic retroviral diseases. Ann. Neurol. 23 (Suppl.), S174-S180.
26. Nakagawa M, Nakahara K, Maruyama Y, Kawabata M, Higuchi I, Kubota H, Izumo S, Arimura K, Osame M (1996) Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. J. Neurovirol. 2, 345-355.
27. Orland JR, Engstrom J, Fridey J, Sacher RA, Smith JW, Nass C, Garratty G, Newman B, Smith D, Wang B, Loughlin K, Murphy EL (2003) Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology 61, 1588-1594.
28. Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A (1987) Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemia-like cells. Ann. Neurol. 21, 117-122.
29. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M (1986) HTLV-I associated myelopathy, a new clinical entity. Lancet 1, 1031-1032.
30. Piccardo P, Ceroni M, Rodgers-Johnson P, Mora C, Asher DM, Char G, Gibbs CJ Jr, Gajdusek DC (1988) Pathological and immunological observations on tropical spastic paraparesis in patients from Jamaica. Ann. Neurol. 23 (Suppl.), S156-S160.
31. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77, 7415-7419.
32. Prince HE, Golding J, York J (1994) Lymphocyte subset alterations associated with increased spontaneous lymphocyte proliferation in human T lymphotropic virus (HTLV) infection: distinctive patterns for HTLV-I versus HTLV-II infection. J. Infect. Dis. 169, 1409-1410.
33. Prince H, Kleinman S, Doyle M, Lee H, Swanson P (1990) Spontaneous lymphocyte proliferation in vitro characterizes both HTLV-I and HTLV-II infection. J. Acquir. Immune. Defic. Syndr. 3, 1199-1200.
34. Prince HE, Swanson P (1993) Spontaneous lymphocyte proliferation in human T lymphotropic virus type II infection is associated with increased provirus load. J. Infect. Dis. 168, 1599-1600.
35. Uchiyama T (1988) Adult T-cell leukemia. Blood Rev. 2, 232-238.
36. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H (1977) Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50, 481-492.
37. Umehara F, Abe M, Koreeda Y, Izumo S, Osame M (2000) Axonal damage revealed by accumulation of beta-amyloid precursor protein in HTLV-I-associated myelopathy. J. Neurol. Sci. 176, 95-101.
38. Wiktor SZ, Jacobson S, Weiss SH, Shaw GM, Reuben JS, Shorty VJ, McFarlin DE, Blattner WA (1991) Spontaneous lymphocyte proliferation in HTLV-II infection. Lancet 337, 327-328.
39. Yamano Y, Machigashira K, Ijichi S, Usuku K, Kawabata M, Arimura K, Osame M (1997) Alteration of cytokine levels by fosfomycin and prednisolone in spontaneous proliferation of cultured lymphocytes from patients with HTLV-I-associated myelopathy (HAM/TSP). J. Neurol. Sci. 151, 163.
40. Zanetti AR, Galli C (1992) Seroprevalence of HTLV-I and HTLV-II. N. Engl. J. Med. 326, 1783-1784.